In vitro evaluation of TLR4 agonist activity: formulation effects.

Misquith, Ayesha; Fung, H W Millie; Dowling, Quinton M; Guderian, Jeffrey A; Vedvick, Thomas S; Fox, Christopher B

Misquith, Ayesha; Fung, H W Millie; Dowling, Quinton M; Guderian, Jeffrey A; Vedvick, Thomas S; Fox, Christopher B.

Afiliação

Misquith A; Infectious Disease Research Institute (IDRI), 1124 Columbia Street, Ste 400, Seattle, WA 98104, USA.
Fung HW; Infectious Disease Research Institute (IDRI), 1124 Columbia Street, Ste 400, Seattle, WA 98104, USA.
Dowling QM; Infectious Disease Research Institute (IDRI), 1124 Columbia Street, Ste 400, Seattle, WA 98104, USA.
Guderian JA; Infectious Disease Research Institute (IDRI), 1124 Columbia Street, Ste 400, Seattle, WA 98104, USA.
Vedvick TS; Infectious Disease Research Institute (IDRI), 1124 Columbia Street, Ste 400, Seattle, WA 98104, USA.
Fox CB; Infectious Disease Research Institute (IDRI), 1124 Columbia Street, Ste 400, Seattle, WA 98104, USA. Electronic address: cfox@idri.org.

Colloids Surf B Biointerfaces ; 113: 312-9, 2014 Jan 01.

Article em En | MEDLINE | ID: mdl-24121074

Assuntos

Adjuvantes Imunológicos/química; Adjuvantes Imunológicos/farmacologia; Receptor 4 Toll-Like/agonistas; Tamanho da Partícula

Palavras-chave

Glucopyranosyl lipid adjuvant; In vitro bioactivity; Particle size; Physicochemical characterization; TLR4 agonist; Vaccine adjuvant formulation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adjuvantes Imunológicos / Receptor 4 Toll-Like Idioma: En Revista: Colloids Surf B Biointerfaces Assunto da revista: QUIMICA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google